Depressive Disorders - Asia | Statista Market Forecast

Revenue in the Depressive Disorders market is projected to reach US$6.11bn in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 1.18%, resulting in a market volume of US$6.48bn by 2029.
In global comparison, most revenue will be generated United States (US$6.26bn in 2024).
In relation to total population figures, per person revenues of US$33.63 are generated in 2024.

Depressive disorders are a common type of mental illness. Symptoms include depressive moods such as feeling sad, low concentration, low self-worth, loss of interest in activities, and, in some cases, thoughts of suicide. Common treatments for depressive disorders include psychological treatments such as psychotherapy, behavioral therapy, and antidepressant medication.

The Depressive Disorders market in the Mental Health market represents the market for antidepressant drug sales. Different types of antidepressants are usually prescribed for the treatment of mild to serious cases of depression, e.g., selective serotonin reuptake inhibitors (SSRIs), serotonin norepinephrine reuptake inhibitor (SNRIs), serotonin modulators, as well as tricyclic and tetracyclic antidepressants.

Market values represent the revenues generated by manufacturers and are based on retail prices for each drug category including all drugs, regardless of whether they are reimbursed or not.

Company examples: Novartis AG, Pfizer, Bristol-Myers Squibb, GlaxoSmithKline, Patheon Inc, and Sandoz Inc.

Antidepressant drugs
Selective serotonin reuptake inhibitors (SSRIs)
Serotonin norepinephrine reuptake inhibitor (SNRIs)
Serotonin modulators
Tricyclic and tetracyclic antidepressants

Psychotherapy
Mood stabilizers
Anti-anxiety and stimulant medications
Behavioral therapy

The Depressive Disorders market in Asia is experiencing significant growth and development.

Customer preferences: Customers in Asia are increasingly seeking treatment for depressive disorders due to several reasons. Firstly, there is a growing awareness and understanding of mental health issues in the region. As stigma surrounding mental health decreases, more individuals are willing to seek help and treatment for their depressive disorders. Secondly, the fast-paced and competitive nature of Asian societies puts individuals at a higher risk of experiencing stress and depression. As a result, there is a greater demand for services and products that can alleviate depressive symptoms and improve mental well-being.

Trends in the market: One of the key trends in the Depressive Disorders market in Asia is the rising demand for pharmaceutical interventions. Antidepressant medications are becoming more widely prescribed and used in the region. This trend can be attributed to several factors. Firstly, there is a growing acceptance and trust in the effectiveness of medication as a treatment for depressive disorders. Secondly, the availability and accessibility of antidepressant medications have increased, making them more accessible to a larger population. Additionally, the development of new and improved antidepressant drugs has also contributed to the increased demand.Another trend in the market is the growing popularity of alternative and complementary therapies for treating depressive disorders. Traditional practices such as acupuncture, herbal medicine, and mindfulness meditation are gaining traction among individuals seeking non-pharmaceutical treatment options. These therapies are often seen as more holistic and natural approaches to mental health, appealing to customers who prefer a more personalized and natural approach to their treatment.

Local special circumstances: The Depressive Disorders market in Asia is influenced by several local special circumstances. Firstly, cultural factors play a significant role in shaping customer preferences and treatment-seeking behaviors. In many Asian cultures, there is a strong emphasis on family and community support. This can influence the type of treatment individuals seek, with many preferring therapy or counseling that involves family members or community support groups.Additionally, the healthcare infrastructure and resources available in each country can impact the development of the market. Countries with well-established healthcare systems and mental health services are likely to have a more developed Depressive Disorders market compared to those with limited resources.

Underlying macroeconomic factors: Several macroeconomic factors contribute to the development of the Depressive Disorders market in Asia. Economic growth and rising incomes in many Asian countries have led to an increase in healthcare spending. As individuals have more disposable income, they are more likely to invest in their mental health and seek treatment for depressive disorders.Furthermore, the aging population in many Asian countries is expected to drive the growth of the Depressive Disorders market. Older adults are more susceptible to depressive disorders, and as the population ages, there will be a greater demand for services and products that cater to their mental health needs.In conclusion, the Depressive Disorders market in Asia is experiencing growth and development due to increasing customer preferences for treatment, trends in pharmaceutical interventions and alternative therapies, local special circumstances such as cultural factors and healthcare infrastructure, as well as underlying macroeconomic factors such as economic growth and the aging population.

Data coverage:

Data encompasses B2C enterprises. Figures are based on companies' revenues, international institutes data, and global consumer survey data. Revenues refer to the retail value and include sales taxes.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use financial reports and third-party data. Next, we use relevant key market indicators and data from country-specific associations such as healthcare spending per capita, medical product spending per capita, and gross domestic product per capita. This data helps us to estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, S-Curve function, ARIMA time series model and exponential curve function. Data is modeled using current exchange rates.

Additional Notes:

The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Despite what some may think, mental health problems are common in the United States and around the world. Mental health issues, much like other health issues, can be mild, but can also be life altering, affecting the emotional, social, and psychological well-being of the person. Common types of mental illness include mood disorders, anxiety disorders, eating disorders, and personality disorders. Although symptoms of mental illness differ depending on the type of illness and seriousness of the problem, common symptoms of mental health issues include changes in sleeping and eating habits, social withdrawal, feelings of hopelessness, anger, and prolonged sadness, suicidal thoughts, and substance abuse. In 2022, it was estimated that around 36 percent of those in the U.S. aged 18 to 25 years and 29 percent of those aged 26 to 49 years suffered from some form of mental illness in the past year.